Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

*Product:*	Children’s Claratyne (Bubblegum flavour)
Active Ingredient:	Loratadine 5mg
Dosage Form:	Chewable tablet
New Zealand Sponsor:	Bayer New Zealand Limited
Manufacturers:	Dragenopharm, Tittmoning, Germany Bayer Healthcare LLC, Pennsylvania, United States of America

*Product:*	Children’s Claratyne
Active Ingredient:	Loratadine 5mg
Dosage Form:	Chewable tablet
New Zealand Sponsor:	Bayer New Zealand Limited
Manufacturer:	Bayer Healthcare LLC, Pennsylvania, United States of America

*Product:*	Nintedanib-Teva
Active Ingredient:	Nintedanib esilate 120.4mg equivalent to Nintedanib 100mg
Dosage Form:	Liquid filled capsule
New Zealand Sponsor:	Teva Pharma (New Zealand) Limited
Manufacturer:	Lotus Pharmaceutical Co Limited, Nantou City, Taiwan

*Product:*	Nintedanib-Teva
Active Ingredient:	Nintedanib esilate 180.6mg equivalent to Nintedanib 150mg
Dosage Form:	Liquid filled capsule
New Zealand Sponsor:	Teva Pharma (New Zealand) Limited
Manufacturer:	Lotus Pharmaceutical Co Limited, Nantou City, Taiwan

Dated this 4th day of August 2025.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule